Pidilite Industries: Navigating Global Headwinds with Strong Domestic Performance in Q3 FY26
Pidilite Industries Limited, a titan in the Indian specialty chemicals sector, has reported a resilient performance for the third quarter of Financial Year 2026. The company, renowned for its iconic brands like Fevicol and Dr. Fixit, demonstrated robust domestic growth that largely offset challenges faced in its export markets. This quarter's results underscore Pidilite's strategic agility and its deep-rooted presence in the Indian consumer and industrial landscape.
For Q3 FY26, Pidilite recorded a consolidated revenue of INR 3,699 crore, marking a commendable 10.2% year-on-year growth. The underlying volume growth (UVG) for the quarter stood at 9.3%, with the domestic business showing particular strength at an 11% UVG. This strong domestic traction was a key highlight, indicating sustained demand across its core markets within India. The company also saw an improvement in its profitability metrics, with gross margins expanding to 55.7% (up 200 basis points from Q3 FY25) and consolidated EBITDA margins reaching 24.2% (up 24 basis points).
Financial Snapshot: Q3 FY26 Consolidated Performance
Note: Staff Costs for Q3 FY26 include a one-time impact of Rs. 53 crore due to the new Labour Code.
Segmental Performance and Strategic Initiatives
The Consumer & Bazaar (C&B) segment continued its robust growth trajectory, reporting a 9.7% UVG. This performance was bolstered by strategic investments in advertising and sales promotion (A&SP), which saw a significant increase of 31.3% in Q3 FY26. Management emphasized that these investments are geared towards building brands for the medium to long term, a classic Pidilite playbook that has consistently yielded results.
In contrast, the Business to Business (B2B) segment experienced a more subdued growth of 2.9% for the quarter. This was primarily impacted by a sharp decline in exports, which fell by 28.8% due to ongoing geopolitical challenges. Despite this, the domestic B2B business maintained a healthy mid-teens growth. Pidilite's management acknowledged the external factors affecting exports but expressed confidence in their
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
